Title : Clinical Trial Simulations From a Model-Based Meta-Analysis of Studies in Patients With Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy.

Pub. Date : 2016 May

PMID : 27299940






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The mOS increased 21% when the AAT was sorafenib (SOR) or 42% when locoregional therapy was coadministered. Sorafenib Moloney sarcoma oncogene Mus musculus
2 The mOS increased 21% when the AAT was sorafenib (SOR) or 42% when locoregional therapy was coadministered. Sorafenib Moloney sarcoma oncogene Mus musculus